Gillessen, Silke, Murphy, Laura, James, Nicholas D, Sachdeva, Ashwin, El-Taji, Omar, Abdel-Aty, Hada, Adler, Amanda I, Amos, Claire, Attard, Gerhardt et al (2025) Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol. The Lancet Oncology, 26 (8). pp. 1018-1030. ISSN 1470-2045
James, Nicholas D, Ingleby, Fiona C, Clarke, Noel W, Amos, Claire L, Attard, Gerhardt, Brawley, Christopher D, Chowdhury, Simon, Cross, William, Dearnaley, David P et al (2022) Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial. JNCI cancer spectrum, 6 (4). pkac043. ISSN 2515-5091
James, Nicholas D., Clarke, Noel W., Cook, Adrian, Ali, Adnan, Hoyle, Alex P., Attard, Gerhardt, Brawley, Christopher D., Chowdhury, Simon, Cross, William R. et al (2022) Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476). International Journal of Cancer, 151 (3). pp. 422-434. ISSN 1097-0215